Safety of Intra-arterial Chemotherapy for NSCLC

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

UTRadRes

New Member
7+ Year Member
Joined
Oct 15, 2013
Messages
1
Reaction score
0
Interesting article on intra-arterial infusion chemotherapy safety and outcomes for advanced lung cancer as an alternative therapy in candidates, who are not ideal for traditional therapies. 47.5% of patients showed response to therapy measured by RECIST criteria with median time to tumor progression of 5 months with minimal side effects.

http://www.jvir.org/article/S1051-0443(13)01089-0/fulltext

I am curious to know if there are a lot on institutions performing arterial directed therapies for other non-liver tumors, not just lung.

Members don't see this ad.
 
Top